CEO Anderson faces pressure to improve Bayer's financial hea...
CEO Anderson faces pressure to improve Bayer's financial health after deciding not to sell its consumer-health business. The effectiveness of cost-cutting plans and cash conversion efficiency remain uncertain. The ongoing Roundup litigation continues to loom over the company's future.
Heard on the Street: Has Bayer Got the Formula to Avoid a Breakup? -- WSJ
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment